Ethical approval
SECONDARY, TUBAL ECTOPIC PREGNANCY
This study is a secondary analysis of data from a multicentre, randomized, double-blind, placebo-controlled trial of combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3) (